HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seth A Hays Selected Research

Vagus Nerve Stimulation

11/2022Vagus nerve stimulation does not improve recovery of forelimb motor or somatosensory function in a model of neuropathic pain.
1/2022Common Cholinergic, Noradrenergic, and Serotonergic Drugs Do Not Block VNS-Mediated Plasticity.
1/2021Vagus nerve stimulation promotes extinction generalization across sensory modalities.
1/2021Optimizing Dosing of Vagus Nerve Stimulation for Stroke Recovery.
1/2021Vagus Nerve Stimulation as a Potential Adjuvant to Rehabilitation for Post-stroke Motor Speech Disorders.
1/2020Efficient parameters of vagus nerve stimulation to enhance extinction learning in an extinction-resistant rat model of PTSD.
1/2020Vagus Nerve Stimulation Paired With Rehabilitative Training Enhances Motor Recovery After Bilateral Spinal Cord Injury to Cervical Forelimb Motor Pools.
1/2020Acute Cardiovascular Responses to Vagus Nerve Stimulation after Experimental Spinal Cord Injury.
1/2019Vagus nerve stimulation promotes generalization of conditioned fear extinction and reduces anxiety in rats.
1/2019Vagus nerve stimulation reverses the extinction impairments in a model of PTSD with prolonged and repeated trauma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seth A Hays Research Topics

Disease

9Stroke (Strokes)
01/2021 - 01/2013
5Ischemic Stroke
01/2019 - 06/2014
4Wounds and Injuries (Trauma)
01/2022 - 04/2016
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021 - 01/2019
3Nervous System Diseases (Neurological Disorders)
01/2020 - 01/2013
3Autistic Disorder (Autism)
01/2017 - 01/2012
3Fragile X Syndrome (Martin Bell Syndrome)
02/2016 - 01/2012
2Spinal Cord Injuries (Spinal Cord Injury)
01/2020 - 01/2020
2Epilepsy (Aura)
01/2017 - 01/2017
2Tinnitus
01/2017 - 01/2013
2Neurodevelopmental Disorders
01/2017 - 02/2016
2Intellectual Disability (Idiocy)
02/2016 - 01/2012
1Neuralgia (Stump Neuralgia)
11/2022
1Pain (Aches)
11/2022
1Speech Disorders (Cluttering)
01/2021
1Mental Disorders (Mental Disorder)
01/2019
1Seizures (Absence Seizure)
02/2016
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016
1Brain Injuries (Brain Injury)
01/2016
1Cerebral Hemorrhage
10/2014
1Ischemia
09/2014
1Hypokinesia (Bradykinesia)
03/2013

Drug/Important Bio-Agent (IBA)

2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2016 - 01/2012
1Proteins (Proteins, Gene)FDA Link
02/2016
1Glutamate Receptors (Glutamate Receptor)IBA
02/2016
1Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
01/2016

Therapy/Procedure

20Vagus Nerve Stimulation
11/2022 - 06/2014
11Therapeutics
11/2022 - 01/2013
1Speech Therapy (Therapy, Speech)
01/2021
1Aftercare (After-Treatment)
01/2021
1Stroke Rehabilitation
09/2014